GO:0005121 Toll binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005121 Toll binding is a molecular function defined as binding to a Toll protein, a transmembrane receptor.
• Toll binding is mediated by diverse ligands and accessory proteins, including MD-2 for TLR4 and galectins from parasites.
• The cytoplasmic Toll/interleukin-1 receptor (TIR) domains of Toll-like receptors exhibit differential binding specificities that dictate downstream signaling.
• Small molecules such as TAK-242 bind selectively to TLR4 and disrupt interactions with adaptor molecules, illustrating the druggability of Toll binding interfaces.
• Toll binding is central to innate immune recognition of pathogens and is implicated in inflammatory, infectious, and neurodegenerative conditions.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of Toll binding events in human cells.
Description
Toll binding (GO:0005121) is a molecular function that describes the physical interaction between a ligand or accessory protein and a Toll protein, which is a transmembrane receptor. Toll proteins were first identified in Drosophila and are conserved across metazoans, where they function as pattern-recognition receptors in innate immunity and as developmental regulators. The binding event is the first step in receptor activation and determines the specificity of downstream signaling. In mammals, Toll-like receptors (TLRs) bind microbial products, endogenous ligands, and synthetic small molecules, often in concert with co-receptors such as MD-2 and CD14. The structural basis of Toll binding has been resolved for several ligand-receptor pairs, revealing that ligand-induced dimerization of the extracellular domain is a common activation mechanism. Because Toll binding initiates inflammatory and developmental signaling cascades, it is a focal point for understanding host defense, autoimmunity, and cancer biology. Researchers study Toll binding to identify therapeutic targets, to map signaling specificity, and to engineer cells with defined receptor responses.
Toll binding At A Glance
| GO ID | GO:0005121 |
|---|---|
| GO term | Toll binding |
| Ontology | molecular_function |
| Synonym | Tl binding, Toll ligand, Toll receptor binding |
| Definition | Binding to a Toll protein, a transmembrane receptor. |
| Major function | Mediates ligand recognition and receptor activation in innate immunity and development. |
| Related cellular component | Plasma membrane; extracellular region |
| Related biological process | Innate immune response; Toll signaling pathway |
| Example ligands | MD-2, galectins, lipopolysaccharide (via accessory proteins) |
What Is GO:0005121?
According to the Gene Ontology, GO:0005121 Toll binding is the molecular function of binding to a Toll protein, which is a transmembrane receptor. This term encompasses interactions between Toll receptors and their ligands, accessory proteins, or other binding partners that occur at the receptor. It is a child of protein binding and is distinct from binding to Toll-like receptor adaptor proteins or to downstream signaling molecules. The function is executed by the extracellular or cytoplasmic domains of Toll proteins and by extracellular ligands or co-receptors that physically associate with them.
Why Is Toll binding Important in Cell Biology?
Toll binding is a critical molecular event because it couples extracellular cues to intracellular signaling that controls inflammation, immunity, and development. Dysregulated Toll binding contributes to chronic inflammatory diseases, sepsis, and neurodegeneration, and it influences tumor progression. Understanding the structural and biochemical rules of Toll binding enables the design of inhibitors and modulators, such as TAK-242, that target specific receptor-ligand interfaces. Moreover, Toll binding specificity determines whether a receptor signals through MyD88 or TRIF adaptor pathways, which has broad implications for host defense and autoimmunity.
• Toll binding initiates innate immune responses against bacterial and viral pathogens.
• It is required for Drosophila embryonic development through Toll receptor-ligand interactions.
• Aberrant Toll binding is linked to neuroinflammation and neurodegenerative disease.
• Parasite-derived galectins can bind Toll-like receptors to promote invasion and inflammation.
• Small-molecule inhibitors of Toll binding, such as TAK-242, are explored as anti-inflammatory agents.
• Toll binding specificity among TLRs shapes differential cytokine production.
• Accessory proteins like MD-2 determine ligand binding and transfer to TLR4.
• Toll binding is a target for vaccine adjuvants and immunotherapies.
• CRISPR screens can identify genes that regulate Toll binding and signaling.
• Structural studies of Toll binding inform rational drug design.
Molecular Mechanism of Toll binding
Ligand Recognition and Initial Contact
In simple terms: The first step is when a ligand or accessory protein physically touches the Toll receptor.
Toll binding begins with the recognition of a ligand by the extracellular domain of a Toll protein. For TLR4, lipopolysaccharide (LPS) is first bound by LBP and CD14, which transfer it to the TLR4-MD-2 complex. MD-2 is an essential accessory protein that binds LPS and presents it to TLR4, forming a stable ligand-receptor complex. In C. elegans, Toll-like receptors bind to Latrophilin proteins to regulate development, demonstrating that Toll binding is not limited to immune ligands. Parasite galectins can also bind TLR4 directly, triggering intestinal inflammation.
Receptor Dimerization and Conformational Change
In simple terms: After binding, two Toll receptors come together and change shape to start signaling.
Ligand binding induces dimerization of Toll receptors, which brings their cytoplasmic TIR domains into proximity. Structural studies of the LPS transfer cascade show that MD-2 and TLR4 undergo conformational changes upon ligand binding, enabling receptor dimerization. The binding specificity of Toll-like receptor cytoplasmic domains determines which adaptor proteins are recruited and whether signaling proceeds through MyD88 or TRIF. This step is critical for signal transduction and is a target for inhibitors that block receptor-receptor interactions.
Accessory Protein and Cofactor Requirements
In simple terms: Other proteins help the ligand bind and the receptor work properly.
Toll binding often requires accessory proteins. MD-2 is indispensable for TLR4 binding to LPS; without MD-2, TLR4 cannot respond to LPS. CD14 and LBP facilitate the transfer of LPS to the TLR4-MD-2 complex. In C. elegans, Latrophilin acts as a binding partner for Toll-like receptors during development. These cofactors increase the specificity and efficiency of Toll binding and are potential therapeutic targets.
Binding Specificity and Regulation
In simple terms: Different Toll receptors bind different partners, and this is tightly controlled.
The cytoplasmic domains of Toll-like receptors exhibit differential binding specificities for adaptor molecules, which dictates downstream signaling outcomes. Small molecules such as TAK-242 bind selectively to TLR4 and interfere with interactions between TLR4 and its adaptor molecules, demonstrating that Toll binding can be pharmacologically modulated. Additionally, viral proteins can suppress extracellular miRNA release, indirectly affecting Toll binding and immune activation. These regulatory layers ensure that Toll binding is context-dependent and tightly controlled.
Key Genes Involved in GO:0005121 Toll binding
The following genes and proteins are central to Toll binding, either as Toll receptors, ligands, accessory proteins, or signaling modulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Toll-like receptor 4; binds LPS via MD-2 | Central to innate immunity and sepsis models |
| LY96 (MD-2) | Accessory protein that binds LPS and presents it to TLR4 | Required for TLR4 ligand binding |
| CD14 | Co-receptor that transfers LPS to TLR4-MD-2 | Facilitates LPS recognition |
| LBP | Lipopolysaccharide-binding protein | Enhances LPS transfer to CD14 |
| TICAM1 (TRIF) | Adaptor protein recruited to TLR4 | Mediates MyD88-independent signaling |
| MYD88 | Adaptor protein for most TLRs | Central to inflammatory signaling |
| TIRAP | Adaptor protein for TLR4 and TLR2 | Links TLRs to MyD88 |
| TLR2 | Toll-like receptor 2; binds lipoteichoic acid | Involved in Gram-positive bacterial recognition |
| TLR3 | Toll-like receptor 3; binds double-stranded RNA | Antiviral immunity |
| TLR5 | Toll-like receptor 5; binds flagellin | Bacterial motility sensing |
| TLR7 | Toll-like receptor 7; binds single-stranded RNA | Antiviral and autoimmune responses |
| TLR9 | Toll-like receptor 9; binds CpG DNA | Bacterial and viral DNA recognition |
| Toll (Drosophila) | Developmental Toll receptor | Embryonic patterning and immunity |
| Latrophilin | Binding partner for Toll-like receptors in C. elegans | Developmental signaling |
| Galectin (Trichinella) | Parasite galectin that binds TLR4 | Host invasion and inflammation |
| TAK-242 target | Small molecule binding TLR4 | Inhibits TLR4 signaling |
| NF-kB subunits | Transcription factors downstream of Toll binding | Inflammatory gene expression |
How Is Toll binding Regulated?
Toll binding is regulated at multiple levels. Accessory proteins such as MD-2 and CD14 control ligand transfer and receptor occupancy. The cytoplasmic TIR domains of TLRs exhibit differential binding specificities for adaptor proteins, which determines signal duration and intensity. Small-molecule inhibitors like TAK-242 can selectively disrupt TLR4-adaptor interactions, showing that binding is druggable. Additionally, viral proteins can modulate extracellular miRNA release, which may indirectly influence Toll receptor activation. These regulatory mechanisms ensure that Toll binding is tightly controlled in space and time.
Toll binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Neuroinflammation, sepsis | TLR4 knockout microglia |
| LY96 (MD-2) | LPS responsiveness, sepsis | MD-2 knockout macrophages |
| TLR4 | Parasite invasion, intestinal inflammation | TLR4 knockout intestinal epithelial cells |
| Toll (Drosophila) | Developmental patterning | Toll mutant Drosophila embryos |
| TLR4 | Inflammatory drug response | TAK-242 treated cells |
Toll binding in neuroinflammation and neurodegeneration
Toll-like receptor 4 binding and downstream NF-kB activation are implicated in microglial inflammatory responses. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via the TLR4/NF-kB pathway, suggesting that modulating Toll binding can reduce neuroinflammation. Dysregulated Toll binding may contribute to chronic neurodegenerative conditions.
Toll binding in infectious disease and parasite invasion
Trichinella spiralis galectin binds Toll-like receptor 4 to induce intestinal inflammation and mediate larval invasion of gut mucosa. This demonstrates that pathogen-derived ligands can exploit Toll binding for host entry and immune evasion. Blocking such interactions could prevent infection.
Toll binding as a therapeutic target in inflammation
TAK-242 (resatorvid) is a small-molecule inhibitor that binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. This highlights the potential of targeting Toll binding interfaces to treat inflammatory diseases. Structural insights into LPS transfer to TLR4-MD-2 further support rational design of inhibitors.
From Toll binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TLR4 binding mediate neuroinflammation? | TLR4 knockout microglia |
| Is MD-2 required for LPS binding to TLR4? | MD-2 knockout macrophages |
| Can parasite galectin bind TLR4 to promote invasion? | TLR4 knockout intestinal cells |
| What is the structural basis of Toll binding? | Point mutations in TLR4 or MD-2 |
| How does Toll binding affect development? | Toll mutant C. elegans or Drosophila |
| Can small molecules disrupt Toll binding? | Overexpression of TLR4 with TAK-242 treatment |
How to Study the Toll binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance | Binding affinity and kinetics | Toll receptor-ligand interactions |
| Isothermal titration calorimetry | Thermodynamics of binding | MD-2-LPS binding |
| X-ray crystallography | 3D structure of complexes | TLR4-MD-2-LPS |
| NF-kB reporter assay | Downstream signaling activation | TLR4 stimulation |
| Cytokine ELISA | Inflammatory cytokine release | Microglia activation |
| CRISPR knockout | Gene requirement for binding | TLR4 knockout cells |
| RNA-seq | Transcriptional changes | Toll binding pathway profiling |
| Co-immunoprecipitation | Protein-protein interactions | TLR4-adaptor binding |
Biochemical binding assays
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) can measure direct binding affinities between Toll receptors and ligands or accessory proteins. These methods have been used to characterize LPS transfer to TLR4-MD-2 and to study small-molecule binding to TLR4.
Structural biology
X-ray crystallography and cryo-electron microscopy reveal the atomic details of Toll binding interfaces. Structural studies of the LPS transfer cascade have elucidated how MD-2 and TLR4 interact, and the structural basis of Toll-like receptor binding to Latrophilin in C. elegans has been resolved.
Cell-based signaling assays
NF-kB reporter assays and cytokine ELISAs measure downstream signaling after Toll binding. These assays have been used to show that ciprofloxacin attenuates microglia inflammatory response via TLR4/NF-kB and that TAK-242 inhibits TLR4 signaling.
Genetic screens and CRISPR
CRISPR knockout screens can identify genes required for Toll binding and signaling. Overexpression of TLR4 or MD-2 can sensitize cells to ligands, while knockout abolishes responses. These approaches are complemented by RNA-seq to profile transcriptional changes.
How CRISPR Can Be Used to Study GO:0005121 Toll binding
Knockout
CRISPR knockout of TLR4, LY96 (MD-2), or CD14 abolishes Toll binding and downstream signaling, providing causal evidence for their roles. Knockout models are essential for validating ligand-receptor interactions and for identifying off-target effects of inhibitors.
Point Mutation
Point mutations in the ligand-binding domain of TLR4 or in MD-2 can disrupt specific binding interfaces without affecting protein expression. Such models help map the structural determinants of Toll binding, as demonstrated by studies of the LPS transfer cascade.
Knock-in
Knock-in of tagged or fluorescently labeled Toll receptors allows real-time imaging of binding events in live cells. This approach can reveal trafficking and localization of Toll receptors during ligand stimulation.
Overexpression
Overexpression of TLR4 and MD-2 in heterologous cells enhances ligand responsiveness and enables biochemical purification of receptor-ligand complexes. This strategy has been used to study TLR4 binding to TAK-242 and to galectins.
How EDITGENE Supports Toll binding Research
Researchers studying Toll binding-related genes often need to determine whether a candidate gene is causally involved in receptor-ligand interactions, signaling, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for Toll binding research.
Frequently Asked Questions About Toll binding
What is Toll binding?
Toll binding is the molecular function of binding to a Toll protein, a transmembrane receptor, as defined by GO:0005121.
What genes are involved in Toll binding?
Key genes include TLR4, LY96 (MD-2), CD14, LBP, MYD88, TICAM1, and other TLRs.
How does Toll binding activate immune signaling?
Ligand binding induces receptor dimerization and recruitment of adaptor proteins, leading to NF-kB activation.
What diseases are associated with Toll binding?
Toll binding is implicated in neuroinflammation, sepsis, parasite invasion, and inflammatory diseases.
Can Toll binding be inhibited by drugs?
Yes, TAK-242 binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.
What is the role of MD-2 in Toll binding?
MD-2 is an accessory protein that binds LPS and presents it to TLR4, forming a stable ligand-receptor complex.
How is Toll binding studied experimentally?
Methods include SPR, ITC, X-ray crystallography, NF-kB reporter assays, and CRISPR knockout models.
What is the difference between Toll binding and Toll-like receptor signaling?
Toll binding is the initial molecular interaction, while signaling encompasses downstream events such as adaptor recruitment and transcription factor activation.
Are there non-immune functions of Toll binding?
Yes, Toll binding regulates developmental processes, as shown by Toll-like receptor binding to Latrophilin in C. elegans.
How can CRISPR help study Toll binding?
CRISPR knockout, knock-in, and overexpression models enable causal testing of genes involved in Toll binding and signaling.
Conclusion
Toll binding (GO:0005121) is a fundamental molecular function that governs innate immune recognition and developmental signaling. Its structural and biochemical mechanisms are increasingly well understood, and its dysregulation contributes to inflammatory and infectious diseases. Targeting Toll binding interfaces with small molecules or biologics holds therapeutic promise. Continued research using CRISPR-engineered models will further elucidate the specificity and regulation of Toll binding in health and disease.
References
- 1. Zusso M et al.. 2019. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.. J Neuroinflammation 16(1):148 PMID: 31319868
- 2. Matsunaga N et al.. 2011. TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.. Mol Pharmacol 79(1):34-41 PMID: 20881006
- 3. Ma KN et al.. 2023. Trichinella spiralis galectin binding to toll-like receptor 4 induces intestinal inflammation and mediates larval invasion of gut mucosa.. Vet Res 54(1):113 PMID: 38012694
- 4. Carmona-Rosas G et al.. 2025. Structural basis and functional roles for Toll-like receptor binding to Latrophilin in C. elegans development.. Nat Struct Mol Biol 32(9):1683-1696 PMID: 40588662
- 5. Ryu JK et al.. 2017. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.. Immunity 46(1):38-50 PMID: 27986454
- 6. Brown V et al.. 2006. Binding specificity of Toll-like receptor cytoplasmic domains.. Eur J Immunol 36(3):742-53 PMID: 16482509
- 7. Visintin A et al.. 2006. MD-2.. Immunobiology 211(6-8):437-47 PMID: 16920483
- 8. Mun H et al.. 2025. SARS-CoV-2 RNA-binding protein suppresses extracellular miRNA release.. RNA Biol 22(1):1-17 PMID: 40590376
